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The discovery of the polymerase chain reaction (PCR) a few
decades ago initiated a global impact on the entirety of the
medical and life sciences research spheres. Nowadays, essen-
tially all laboratories focusing on such vital research employ
in-house PCR techniques on a near-daily basis, due to the
wide spectrum of applications which PCR technology can
adopt itself to, such as cloning and medical diagnostics to
name but a few. In addition, the cost for purchasing and
maintenance of basic PCR equipment such as thermal cyclers
and real time PCR platforms is within reach of most labora-
tories with adequate research funds.
The combined sensitivity, reproducibility and
cost-effectiveness of PCR technology consequently allowed
for the refined development for applications in the fields of
quantitative genomics and transcriptomics analytical meth-
ods, such as gene expression analyses. Furthermore, the
emergence of novel non-coding RNA molecular families,
such as micro RNAs (miRNAs) and long non-coding RNAs
(lncRNAs), as novel key regulators of gene expression only
serve to augment the importance of quantitative PCR tech-
nology as a powerful research tool within the context of such
research fields. A typical example of such applications is the
utilization of high throughput reverse transcription quanti-
tative PCR (RT-qPCR) for whole genome miRNA expression
profiling.1
Unfortunately, ubiquitously available and affordable tech-
nologies, such as RT-qPCR, do have a major passive draw-
back: inter-laboratory reproducibility. Variations in the rou-
tine methodologies implemented by individual laboratories
can inevitably lead to severe lapse of data robustness and
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The discovery of the polymerase chain reaction (PCR) a few decades ago initiated a global impact on the entirety of the medical
and life sciences research spheres. Nowadays, essentially all laboratories focusing on such vital research employ in-house PCR
techniques on a near-daily basis, due to the wide spectrum of applications which PCR technology can adopt itself to. Unfortu-
nately, ubiquitously available and affordable technologies, such as RT-qPCR, do have a major passive drawback: in-
ter-laboratory reproducibility. Variations in the routine methodologies implemented by individual laboratories can inevitably
lead to severe lapse of data robustness and reliability for publication in peer-reviewed journals. In order to address this pressing
issue, a consortium of eminent research group leaders in the field of RT-qPCR technology decided to propose a distinct set of
standardized guidelines for the reporting of RT-qPCR study results, known as the Minimum Information for Publication of
Quantitative Real Time PCR Experiments (MIQE), which were published in early 2009. This concept is very much similar to
the one leading to the development of the Minimum Information for Microarray Experimets (MIAME) guidelines for reporting
of microarray-based studies. In order to address this pressing issue, a consortium of eminent research group leaders in the field
of RT-qPCR technology decided to propose a distinct set of standardized guidelines for the reporting of RT-qPCR study results,
known as the Minimum Information for Publication of Quantitative Real Time PCR Experiments (MIQE), which were pub-
lished in early 2009. This concept is very much similar to the one leading to the development of the Minimum Information for
Microarray Experimets (MIAME) guidelines for reporting of microarray-based studies.
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reliability for publication in peer-reviewed journals. These
variations can occur at differing stages of the RT-qPCR pro-
cedure include the stringency levels involved in target gene
primer assay designs, quality of handling and/or storage of
clinical RNA samples, efficiency of RNA extraction and/or
reverse transcription protocols, and normalization methods
utilized for relative quantification of RT-qPCR data obtained
post-run. Consequently, such a lack of standardization re-
garding essential methodologies and practices pertaining to
the RT-qPCR process ultimately leads to the production of
non-reproducible data. This obtained data can, essentially, be
of no concrete value and should therefore not be deemed fit
for publication by scientific journals. However, the lack of
clear standards and guidelines can easily allow such situa-
tions to take place, possibly within well -respected scientific
journals as well.
In order to address this pressing issue, a consortium of emi-
nent research group leaders in the field of RT-qPCR tech-
nology decided to propose a distinct set of standardized
guidelines for the reporting of RT-qPCR study results,
known as the Minimum Information for Publication of
Quantitative Real Time PCR Experiments (MIQE), which
were published in early 2009.2 This concept is very much
similar to the one leading to the development of the Mini-
mum Information for Microarray Experimets (MIAME)
guidelines for reporting of microarray-based studies.3
The MIQE guidelines consist of a ‘checklist’ of essential and
desirable information parameters relating to each individual
step of the RT-qPCR experimental procedure.2 Highlights of
these guidelines include the importance of reporting all pa-
rameters required for the design of efficient primer sets for
each individual target and reference gene investigated in any
particular study.
This includes (but not limited to) the reporting of the full
primer sequences, target gene accession number, target gene
region (ie. Whether intron spanning or otherwise, splice
variant possibilities, etc.), secondary structure formations of
the individual primers and target template sequence, primer
set homology search and target template region single nu-
cleotide polymorphism (SNP) / other mutation check meth-
odologies. The development of individual standard curves for
each individual primer set utilized in the RT-qPCR study is
also required to confirm the dynamic range and efficiency of
the primer set to allow for a successful PCR run. Any primer
sets that fail to produce efficient standard curves should be
removed from utilization in the study and new primer sets
should be designed accordingly.
The MIQE guidelines also stress the importance of ensuring
that clinical samples and consequent extracted RNA are to be
handled and stored in the appropriate manner. Furthermore,
researchers should include parameters such as the level of
RNA purity and integrity for each individual clinical sample
utilized in their RT-qPCR study.
Other major parameters that require to be reported include
the RNA input amounts utilized in the reverse transcription
step, type of reverse transcription enzyme and the priming
method employed for such measure. The necessity to im-
plement more than just one reference gene (and with prior
validation) for the relative quantification RT-qPCR tech-
nique is also clearly stressed within the MIQE guidelines.
Ultimately, this checklist should be utilized as a fixed refer-
ral point for all researchers embarking on RT-qPCR research
studies, in order to ensure that all their RT-qPCR protocols
adhere to the guidelines present on the MIQE checklist prior
to submission of research results for publication. Similarly,
the recent emergence of digital qPCR technology has moti-
vated the MIQE consortium to develop an publish the digital
MIQE guidelines for proper utilization and scientific report-
ing of research studies employing this novel technology.4
Leading members of the MIQE consortium recently pub-
lished in Nature Methods the results of a survey in over 1700
RT-qPCR publications, examining the level of adherence by
researchers to the MIQE guidelines when reporting such
studies.5 The results of this survey revealed that for
RT-qPCR studies published between 2009 and 2011, overall
adherence to MIQE guidelines was reduced particularly in
publications from scientific journals having an Impact Factor
of 10 or higher.5 For studies published between 2012 and
2013, the levels of reporting qPCR study results in compli-
ance with the MIQE standards was increased.5 Sadly, this
was not the case for publications from leading, very high
impact factor journals during the same time period.5
In conclusion, the widespread accessibility to qPCR tech-
nology has allowed for its own abuse due to the ongoing
reporting of poorly conceived qPCR datasets through inap-
propriate and/or lack of standards in the various stages of the
qPCR experimental design and procedure. More alarming is
the fact that, particularly for high Impact Factor scientific
journals, there is a pressing urge to apply added scrutiny by
the journal-appointed peer-reviewers, of scientific manu-
scripts bearing clinical / research affirmations based on qPCR
data findings, prior to their publication.
Fortunately, since its inception in 2009, the concept of
standardization and streamlined reporting of qPCR data
through dissemination of the MIQE guidelines is gradually
seeping into the minds of researchers. This consequently
ensures that precious research efforts can be deemed to
translate into a robust piece of scientific evidence having
reliable clinical value, and upon which other peer research-
ers can build on. Time will tell about the long-term effects of
the MIQE revolution, though at present, its voice is already
being heard.
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